Yukihiko Nishizawa

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma

Yoshinari Shinsato, Tatsuhiko Furukawa, Shunji Yunoue et al. · Oncotarget · 2013 · 78 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Abcb10 Role in Heme Biosynthesis <i>In Vivo</i>: Abcb10 Knockout in Mice Causes Anemia with Protoporphyrin IX and Iron Accumulation

Masatatsu Yamamoto, Hiroshi Arimura, Tomoko Fukushige et al. · Molecular and Cellular Biology · 2014 · 67 citations · Full text

Medicine, Cell Biology, Genetics +17

Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors

Kentaro Minami, Yoshinari Shinsato, Masatatsu Yamamoto et al. · Journal of Pharmacological Sciences · 2015 · 64 citations · Full text

Medicine, Oncology, Pharmacology +17

VEGF expression is augmented by hypoxia-induced PGIS in human fibroblasts

Jia Wang, Ryuji Ikeda, Xiaofang Che et al. · International Journal of Oncology · 2013 · 26 citations · Full text

Medicine, Molecular Biology, Oncology +16

Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells

Ryuji Ikeda, Yukihiko Nishizawa, Yusuke Tajitsu et al. · Oncology Reports · 2013 · 25 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12